Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease.

J Oncol · 2016 · PMC4763009 · PMID 26977148

Europe PMC DOI

hedged sentences

0.0520

closest p · 1.0× alpha

0.0800

boldest claim

The sentences

showed a trendP = 0.052so close (0.05 < p ≤ 0.1)

The response to initial treatment showed a trend towards superiority in the rhTSH group compared to the THW group ( P = 0.052).

also in 53,322 other papers

did not reach statistical significanceP = 0.08so close (0.05 < p ≤ 0.1)

There were less male patients (19%) in the THW group than in the rhTSH group (40%), although this difference did not reach statistical significance ( P = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.